Last Posted: Jul 26, 2019
- PARP inhibition - opportunities in pancreatic cancer.
Pant Shubham et al. Nature reviews. Clinical oncology 2019 Jul - Clinically Applicable Deep Learning Algorithm Using Quantitative Proteomic Data.
Kim Hyunsoo et al. Journal of proteome research 2019 Jul - Has Personalized Medicine for Pancreatic Cancer Arrived?
Krepline Ashley et al. Advances in surgery 2019 Sep 53103-115 - Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma.
Cheng Yang et al. EBioMedicine 2019 Feb 40382-393 - Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localised pancreatic cancer.
Lee B et al. Annals of oncology : official journal of the European Society for Medical Oncology 2019 Jun - Familial pancreatic cancer risk: a population-based study in Utah.
Kohli Divyanshoo R et al. Journal of gastroenterology 2019 Jun - Trial Highlights Complexities of Targeted Therapy for Pancreatic Cancer
NCI, June 2019 - Genetics of pancreatic cancer and implications for therapy.
Bhosale Priya et al. Abdominal radiology (New York) 2018 43(2) 404-414 - Next-Generation Sequencing in Pancreatic Cancer.
Shen Gong-Qing et al. Pancreas 2019 Jul 48(6) 739-748 - Clinical characteristics and outcomes in elderly women with BRCA1 and BRCA2 mutations.
Salyer Chelsea et al. Gynecologic oncology 2019 May
.png)
No hay comentarios:
Publicar un comentario